Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03602105
Other study ID # 2018/503
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date March 31, 2026

Study information

Verified date November 2023
Source Oslo Metropolitan University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Health professions need to prepare for the large increase in the number of older people with OA requiring health services including TJA surgery. Older age and poor physical function influences the postoperative prognosis of TJA. At discharge from hospital after TJA, studies have shown that gait speed can be severely impaired among older patients. The investigators hypothesize that an exercise program of 6-12 weeks will be beneficial for patients that are undergoing TJA.


Description:

More than 300.000 Norwegians above 20 years of age have osteoarthritis (OA) . There has been a significant increase in the prevalence of OA over the decades. In the United States knee OA affects 19% of adults aged 45 years or older. OA is associated with an extensive high economic and personal burden, largely attributable to the effects of disability, comorbid disease, and the expense of treatment. Given the aging population, the number of total joint arthroplasty procedures (TJA) for hip and knee is likely to increase substantially. In light of poor physical function prior to surgery among older patients and the likelihood of an added decrease during hospitalization and risk of poorer outcome after surgery, it is hypothesised that prehabilitation (preoperative exercise) would improve outcomes after surgery, however evidence for its efficacy is still lacking


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 103
Est. completion date March 31, 2026
Est. primary completion date May 30, 2024
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria: - Participants 70 years or older living at home with residential address in the county of Oslo or Akershus scheduled for elective primary total hip replacement due to end-stage osteoarthritis. - Harris Hip Score >60. - Participants must also be capable in Norwegian and be able to follow exercise sessions. Exclusion Criteria: - Patients with known rheumatoid arthritis or medical contraindications or those who are scheduled for revision of hip arthroplasty - Unable to speak and understand the Norwegian language. - Patients with neurological disorders affecting gait - Medical contraindications for exercise

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise
Exercises in group and/or individually

Locations

Country Name City State
Norway OsloMet Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo Metropolitan University

Country where clinical trial is conducted

Norway, 

References & Publications (3)

Bitton R. The economic burden of osteoarthritis. Am J Manag Care. 2009 Sep;15(8 Suppl):S230-5. — View Citation

Slatkowsky-Christensen B, Grotle M. Artrose i Norge. Norsk Epidemiologi 2008;18(1)

Wallace IJ, Worthington S, Felson DT, Jurmain RD, Wren KT, Maijanen H, Woods RJ, Lieberman DE. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9332-9336. doi: 10.1073/pnas.1703856114. Epub 2017 Aug 14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in gait speed 40 meters Fast-Paced Walk test Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention
Secondary Change in physical function 30 second sit-to stand test Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention
Secondary Change in aerobic capacity 6 min walk test 1 week before intervention, directly after intervention as well as 6 and 12 weeks after TJA-surgery
Secondary Change in transitional ambulation Timed-up and go Test (TUG) Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention
Secondary Change in pain measured with numeric rating scale (NRS) NRS - Single score, low score indicates low pain, high score indicated high levels of pain Change measure: Baseline, within one week after intervention, 6 weeks after intervention and 3 months after intervention
Secondary Length of stay in hospital Number of days From date of hospital admission until the date of hospital discharge, assessed up to 12 months
Secondary Change in the ability to climb stairs Stair-climb test. Timed performance from start to stop Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention
Secondary Change in Health Status measured with EuroQol-5 dimensions (EQ-5D) EQ-5D, five dimensions of health scored from 1-5, with 1 being no problem and 2-5 indicate increasing problem (higher score = increase in problem) Change measure: Baseline, within one week after intervention, 6 weeks after intervention, 3 months after intervention, 6 months after intervention and 12 months after intervention
See also
  Status Clinical Trial Phase
Completed NCT05065775 - Bioavailability of Intranasal Dexmedetomidine Phase 4
Completed NCT03540667 - Study of Hip and Knee Arthroplasty in South Africa
Completed NCT04441112 - Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial Phase 2/Phase 3
Recruiting NCT05366712 - Nexus Evaluation Primary Trident II Uncemented Shell N/A
Completed NCT03375112 - Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty Phase 4
Not yet recruiting NCT05736016 - Medial Wedge Insoles to Improve Gait in Persons After Total Hip Replacement N/A
Recruiting NCT05957822 - Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery Phase 4
Not yet recruiting NCT05956769 - Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty N/A
Completed NCT03069183 - Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Total Hip Arthroplasty Phase 2/Phase 3
Enrolling by invitation NCT04928924 - Immediate Post-THA Functional Assessment